Persistent Bloating in Mid-Life: Beyond Diet

A 46-year-old patient brought a phone full of progress photos to her first visit — same shirt, same lighting, taken across the day. By 6 PM her abdomen looked four months pregnant. She had eliminated gluten, then dairy, then FODMAPs, then nightshades, then alcohol, then carbonated drinks. She had spent two thousand dollars on food sensitivity panels. Her gastroenterologist had cleared her with a normal colonoscopy and told her it was probably IBS. She still felt swollen, uncomfortable, and unrecognizable in her own clothes by mid-afternoon. Nothing she tried held.

I see this presentation in my practice every week. Persistent bloating in a woman in her 40s or early 50s that does not respond to dietary elimination is rarely a food problem. It is usually a hormonal, inflammatory, or motility problem layered on top of normal eating, and the workup that finds the actual driver is not a food diary — it is a panel.

Why the diet-first approach so often fails this patient

There is nothing wrong with thinking about food when bloating starts. For some patients, an unrecognized intolerance, true celiac disease, or a SIBO process is the answer and dietary change resolves it. But when a patient has done a thorough elimination, gotten cleared by GI, and the bloating persists or recurs, the issue is almost always upstream of what they are eating.

The most common drivers I identify in mid-life women with persistent bloating that has resisted dietary intervention:

Estrogen-progesterone imbalance through perimenopause. As cycles become irregular and progesterone declines disproportionately to estrogen, the relative estrogen excess produces fluid retention, slows gut motility, and contributes directly to abdominal distension. Patients describe bloating that tracks loosely with the cycle in early perimenopause and becomes nearly constant as ovarian function declines further.

Thyroid dysfunction, often subclinical. A sluggish thyroid slows everything, including gut motility. I find patients with TSH in the upper half of "normal," free T3 sitting at the floor of the range, and elevated reverse T3 — none of which any single value would flag, but together they tell a clear story. Constipation, slow transit, abdominal distension, and fatigue cluster in this pattern.

Cortisol dysregulation. Chronic stress flattens the cortisol curve and elevates evening cortisol, which directly disrupts digestion, slows gastric emptying, and shifts the gut microbiome. The patient who is bloated worse at the end of a stressful workday is often dealing with cortisol mechanics, not food choices.

Insulin resistance and visceral adiposity. Mid-life weight redistribution toward the abdomen — even without significant weight gain on the scale — produces a measurable change in waist circumference and a real change in how the abdomen looks and feels through the day. The "bloating" the patient is describing is partly true distension, partly the new baseline of central adiposity that estrogen decline has uncovered.

Pelvic floor dysfunction. Often missed. As estrogen declines, pelvic floor support changes, and patients can develop functional bowel patterns that present as bloating. A pelvic floor physical therapy referral is sometimes the answer when the medical workup is otherwise unremarkable.

Medication contributors. SSRIs, opioids, calcium channel blockers, iron supplements, and PPIs all slow motility or alter the gut microbiome. The patient who started a new medication six months before the bloating began deserves a careful medication review.

The mistake is approaching this as a single-cause problem. In my experience two or three of these contributors operate at once, and the workup needs to surface all of them before a treatment plan can be built.

The mechanism — why hormones change how your gut behaves

Estrogen and progesterone are not just sex hormones. They have receptors throughout the gastrointestinal tract and they directly influence motility, secretion, and visceral sensitivity.

Progesterone slows smooth muscle contraction. That is why constipation increases in the luteal phase of a cycle and during pregnancy. As progesterone declines erratically through perimenopause, motility patterns become unstable — patients describe alternating constipation and looser stools, increased gas, and a sense that "nothing is moving right."

Estrogen modulates visceral sensitivity. Receptors in the gut wall make the gut more or less sensitive to distension at different estrogen levels. A volume of gas that produced no symptom at 35 can produce significant discomfort at 48 because the threshold has shifted, not because the gas has increased.

Both hormones affect the gut microbiome. The estrobolome — the subset of gut bacteria that metabolize estrogens — shifts as endogenous estrogen production declines. That shift changes which bacterial species predominate and how the gut handles fermentable carbohydrates, which is why a diet that worked at 38 may not work at 48.

Thyroid hormone directly drives smooth muscle contraction throughout the gut. Even mild hypothyroidism produces measurably slower transit. The clinical picture is constipation, abdominal fullness, and the sense that food sits longer than it should.

Cortisol affects gastric emptying, intestinal permeability, and the microbiome. The gut and the HPA axis are bidirectionally wired; changes in either system propagate to the other. This is why stress management is not optional in this workup — it is part of the mechanism.

How I evaluate persistent bloating in mid-life

When I evaluate a patient for this complaint, the workup is broader than a typical GI workup because the GI workup has usually already been done.

The history I take focuses on:

• Onset and pattern — when did this start, how does it vary through the day and through a cycle if cycles are still present
• Cycle history if applicable — are cycles still regular, has cycle length or flow changed
• Bowel pattern — frequency, consistency, urgency, sense of incomplete evacuation
• Other perimenopausal symptoms — sleep changes, hot flashes, mood shifts, libido changes, joint pain
• Diet history — what has been tried, what changed with each elimination, what did not
• Medication and supplement list — including OTCs, fiber supplements, and probiotics
• Stress, sleep, and exercise patterns
• Prior GI workup — what was done, what was found, what was ruled out

The lab panel I run includes:

• Sex hormones — estradiol, progesterone, total and free testosterone, DHEA-S, SHBG
• Full thyroid panel — TSH, free T3, free T4, reverse T3, thyroid antibodies (anti-TPO and anti-TG)
• Metabolic markers — fasting insulin, HbA1c, fasting glucose, lipid panel, liver enzymes
• Inflammatory and nutritional markers — hs-CRP, ferritin, vitamin D, B12, magnesium
• Sometimes additional markers based on the picture — celiac serology if not previously done, H. pylori if reflux is part of the picture, GI mapping if SIBO is still on the differential

I do not run every test on every patient. The panel is matched to what the history suggests. But I run it broad enough on the first pass that I am not chasing one finding while missing the actual driver.

What treatment looks like once a cause is identified

Treatment is built around what the workup reveals.

For the perimenopausal patient with low progesterone and a relative estrogen excess, hormone optimization with bioidentical progesterone often produces meaningful improvement in bloating within four to six weeks. The mechanism is direct — restoring the progesterone signal stabilizes motility and reduces fluid retention.

For the patient with subclinical thyroid dysfunction, the conversation is whether the picture warrants treatment. A TSH of 3.2 with low-normal free T3 and elevated reverse T3 in a symptomatic patient is a different decision than the same numbers in an asymptomatic patient. When the picture warrants it, low-dose thyroid support often resolves bloating within the same window it improves energy and constipation.

For the patient where insulin resistance and central adiposity are central, the metabolic program addresses the underlying physiology. As insulin sensitivity improves and visceral fat declines, the abdominal distension reduces measurably and durably.

For male patients with similar presentations, men's hormone therapy sometimes plays a role when low testosterone is driving central adiposity and metabolic dysfunction.

For cortisol-driven patterns, the work is structural — sleep, stress management, sometimes adaptogenic support, occasionally a focused conversation about workload that the patient has not previously been willing to have.

For medication-driven patterns, the answer is a medication review with the prescribing provider.

What I tell patients about timeline

For purely hormonal drivers, expect a noticeable shift in 4 to 6 weeks and full optimization by 3 months. For metabolic drivers, the markers shift within 6 to 8 weeks but the body composition change that resolves the abdominal distension is a 3 to 6 month process. For thyroid corrections, symptomatic improvement begins around week 4 with full response at 8 to 12 weeks. Combined drivers respond on the longest of these timelines, not the shortest.

The patients who do best engage with all the contributors the workup identifies, not just the easiest one.

Concrete next step

If you have done the dietary work and the bloating has not resolved, the useful next step is a real workup — not another elimination diet. Order comprehensive lab work at the first consultation, run the full hormonal and metabolic panel, and bring whatever GI workup you have already had so we are not duplicating tests. Book a Columbus consultation or Warner Robins consultation and come prepared to walk through the timeline, the patterns, and what has been tried. The picture usually becomes clear in two visits, and the treatment plan that follows is built on what the data actually shows.

*Information in this article is educational and does not constitute medical advice. Consultation and lab work are required before any treatment is recommended. Individual results vary.*

TW

Travis Woodley

MSN, RN, CRNP — Platinum Biote Provider — Founder, Revitalize

Travis spent 17+ years in high-acuity clinical medicine — emergency, cardiac ICU, and cath lab — before founding Revitalize. He is a Certified Platinum Biote hormone therapy provider, the published author of You're Not Broken — You're Unbalanced, and the founder of the Rebuild Metabolic Health Institute. His clinical writing reflects the same precision he brought to critical care: specific, honest, and built around what actually works.

Book a ConsultationCall (762) 261-3880

About Travis →More articles →Rebuild Institute →